Infant immune response to hepatitis B vaccine after fetal exposure to telbivudine

Whether telbivudine (LdT) treatment to pregnant women with hepatitis B surface antigen (HBsAg) affects infant immune response to hepatitis B vaccine (HepB) has not been investigated. A total of 127 HBsAg positive mothers and their neonates were enrolled and followed up at 11–13 months. Mothers took...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yandi, Chen, Wenxin, Jin, Cong, Wang, Ting, Yao, Tian, Feng, Shuying, Wang, Bo, Feng, Yongliang, Wang, Suping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Hepatitis – Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993090/
https://www.ncbi.nlm.nih.gov/pubmed/35296227
http://dx.doi.org/10.1080/21645515.2022.2029259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993090/
https://www.ncbi.nlm.nih.gov/pubmed/35296227
http://dx.doi.org/10.1080/21645515.2022.2029259

Ejemplares similares